Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2022 07:30 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe

POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
August 23, 2022 12:09 ET | Source: The Joint Commission

Peer supporters at risk for emotional exhaustion during COVID-19 pandemic

OAKBROOK TERRACE, Illinois, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Peer support is an effective, well-received approach for healthcare professional colleagues who face stress, challenges, and reduced...
August 18, 2022 09:00 ET | Source: University of Minnesota Medical School

COVID OUT clinical trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment

MINNEAPOLIS/ST. PAUL, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Published in the New England Journal of Medicine, researchers — led by the University of Minnesota Medical School and School of Public Health...
August 09, 2022 18:00 ET | Source: Doctivity Inc.

Doctivity™ Names National Healthcare Leaders to Its Board of Directors and Advisory Board

BLOOMSBURG, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) -- - Doctivity™ announced today the appointment of experienced national healthcare leaders to its Board of Directors and Advisory Board: Michael...
July 26, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA

MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a commercial-stage company focused on improving the quality of life for people with fluid overload, today announced the...
July 25, 2022 20:26 ET | Source: Humacyte, Inc

Humacyte Preclinical Data on Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary Artery Bypass Grafting (CABG) Presented at American Heart Association Meeting

-- Preclinical model data expected to support development of small diameter HAV to treat patients with coronary artery disease-- -- Small-diameter HAV observed to maintain patency and exhibit...
July 19, 2022 08:00 ET | Source: Humacyte, Inc

Humacyte Announces Presentation of Preclinical Data on the HAV™ in Coronary Artery Bypass Grafting at the Basic Cardiovascular Sciences Scientific Sessions

DURHAM, N.C., July 19, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues, today...
July 07, 2022 16:05 ET | Source: Oil-Dri Corporation Of America

Dr. Aldo Rossi Joins a Growing Amlan International Team in the Americas

CHICAGO, July 07, 2022 (GLOBE NEWSWIRE) -- Amlan International, a global leader in mineral-based feed additives that support poultry and livestock gut health, announces the appointment of Dr. Aldo...
July 06, 2022 16:05 ET | Source: Portage Biotech, Inc.

Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway

Acquires two clinical-stage, best in class adenosine compounds, and two preclinical assets for approximately $21 million upfront consideration Rob Glassman, M.D., Ph.D., director of Tarus and...
June 29, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HF

MINNEAPOLIS, June 29, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the first patient has been enrolled in the company’s pivotal REVERSE-HF (Ultrafiltration Versus IV...